
Aridis Pharmaceuticals ARDS
Quartalsbericht 2023-Q3
hinzugefügt 06.11.2023
Aridis Pharmaceuticals P/S 2011-2026 | ARDS
P/S Jährlich Aridis Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.34 | 14.5 | 17.4 K | 58.7 | 10.4 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 17.4 K | 1.34 | 3.5 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
11.7 | $ 2.11 | -13.17 % | $ 217 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.52 | -2.12 % | $ 2.59 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 164.13 | 0.15 % | $ 8.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.49 | -3.11 % | $ 15.6 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
BridgeBio Pharma
BBIO
|
26.1 | $ 64.24 | -3.37 % | $ 12.3 B | ||
|
BioAtla
BCAB
|
747 | $ 0.18 | -26.92 % | $ 8.6 M | ||
|
BioCardia
BCDA
|
18.6 | $ 1.37 | 6.2 % | $ 29 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 8.61 | -1.66 % | $ 1.78 B | ||
|
Beam Therapeutics
BEAM
|
22.9 | $ 28.29 | -0.6 % | $ 2.8 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 11.47 | -0.43 % | $ 742 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Biogen
BIIB
|
2.97 | $ 187.68 | -2.16 % | $ 27.5 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 60.68 | -1.7 % | $ 11.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
2.54 | $ 62.54 | 0.27 % | $ 127 B | ||
|
Benitec Biopharma
BNTC
|
54.5 | $ 10.85 | -0.5 % | $ 447 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 109.85 | -0.34 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.63 | -2.69 % | $ 4.13 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 8.6 | 1.9 % | $ 1.39 B |